Objective: To study organism-specific platelet response and factors affecting survival in thrombocytopenic very low birth weight (VLBW) babies with sepsis.
Introduction
Neonatal sepsis is a clinical syndrome characterized by systemic signs of infection and bacteremia during the first 28 days of life. Sepsis continues to be the most important cause of neonatal mortality, especially in very low birth weight (VLBW) babies, and clinical presentation in these tiny babies can be subtle and nonspecific. [1] [2] [3] Thrombocytopenia is used as a nonspecific marker for sepsis in neonates. 4, 5 However, not much is known about the effect of different organisms on various platelet parameters, especially in thrombocytopenic VLBW babies with sepsis. 6, 7 Hence, we decided to study the effect of different organisms on various platelet parameters in thrombocytopenic very low birth weight babies with sepsis and also to study the factors affecting survival in these babies.
Materials and methods
The study was conducted from January 2000 to December 2005 in the neonatal intensive care unit of Sheri-Kashmir Institute of Medical Sciences, a tertiary care hospital in northern India. All VLBW (birth weight <1500 g) babies who were admitted during this period were evaluated prospectively for evidence of sepsis. Sepsis was defined according to the International Sepsis Definition Conference 8 as 'clinical syndrome characterized by the presence of both infection and systemic inflammatory response syndrome.' Systemic inflammatory response syndrome in the case of neonates is defined as two or more of the following: (1) tachypnea (respiratory rate >60 bpm) plus grunting/retractions or desaturation, (2) temperature instability (<36 1C or >37.9 1C), (3) capillary refill time >3 s, (4) white blood cell count (<5000 Â 10 9 per l or >34000 Â 10 9 per l), (4) CRP>10 mg per 100 ml or >2 s.d. above normal value, (5) interleukin 6 or 8 >70 pg ml À1 , (6) procalcitonin >8.1 mg per 100 ml or >2 s.d. above normal value. [9] [10] [11] [12] [13] Sepsis is defined as one or more systemic inflammatory response syndrome criteria with signs of infection. Severe sepsis is defined as sepsis associated with hypotension or single-organ dysfunction. Septic shock is defined as severe sepsis with hypotension requiring fluid resuscitation with inotropic support. Multiorgan dysfunction syndrome is defined as the presence of multiorgan failure despite full supportive treatment. Sepsis in our study was defined as a positive blood culture in the presence of clinical signs and symptoms of infection.
14 Only the first episode of sepsis in a patient was included to avoid any confounding effects of earlier sepsis on platelets. Sepsis evaluation was based on clinical signs and symptoms and rapid screen tests for sepsis, including changes in complete blood counts and positive blood culture. Persistent bacteremia was defined as three or more consecutive positive blood cultures in a single sepsis episode. Babies with congenital malformations and chromosomal anomalies were excluded. This study was approved by the ethics committee of Sheri-Kashmir Institute of Medical Sciences.
Blood for culture (1 ml of blood) and complete blood counts was obtained by means of venipuncture. Platelet count and mean platelet volume (MPV) determinations were carried out on a coulter counter. In babies with a positive blood culture, repeat cultures were sent every 48 h till the culture was sterile. The initial complete blood count used for the study was the one obtained either with the blood culture or the one closest to the time the positive blood culture was drawn. The patients with suspect sepsis were treated initially with cefotaxime and amikacin, as is the policy in our unit, and later, antibiotics were changed according to the culture sensitivity report and the response of the baby to the initial antibiotics. Culture-positive sepsis without meningitis was treated for 14 days after blood culture was sterile, and meningitis was treated for 21 days. Nosocomial sepsis (defined as an infection that occurs 48 h after admission, in a baby who did not have any evidence of an infection on admission, characterized by the growth of a pathogen not related to infection at another site from one blood culture or a positive PCR in the presence of clinical features of infection) was treated with immipenem and vancomycin. Early onset/perinatal sepsis was defined as infection during the first 72 h of life and late onset/postnatal sepsis as infection occurring after 72 h of life. The platelet parameters studied include total platelet count, incidence of thrombocytopenia, duration of thrombocytopenia, platelet nadir, change in platelet count and MPV. Thrombocytopenia was defined as platelet count <100 Â 10 9 per l. The incidence of thrombocytopenia was the number of sepsis episodes with a platelet count <100 Â 10 9 per l. The duration of thrombocytopenia was the number of continuous days during which the platelet count remained below 100 Â 10 9 per l. Platelet nadir was the lowest platelet count obtained for that neonate starting from the period in which blood culture was drawn. The change in platelet count was defined as the percentage change in platelet count at the time of onset of sepsis as compared with the initial platelet count obtained at least 24 h before the time positive blood culture was obtained. Platelet count data were not adjusted for platelet transfusions. Platelet transfusions were ordered when the total platelet count was <20 Â 10 9 per l or <50 Â 10 9 per l, with clinical evidence of bleeding. The change in MPV was defined as the difference between the initial mean platelet volume (MPV 2 ) at the time of sepsis and a baseline value (MPV 1 ) before the onset of sepsis.
Stastical analysis was performed using multivariate analysis of variance, Mann-Whitney U, Krussal-Wallis and w 2 tests. Table 1 . There were no differences between the groups, except for mortality, which was more in babies with Gramnegative and fungal sepsis. Furthermore, the factors that affect platelet count or alter the risk of sepsis, including necrotizing enterocolitis (stage 2 or 3, according to Bell-staging criteria with the Walsh and Kleigman modification), prolonged rupture of membranes (>18 h), chorioamnionitis (clinical criteria) or preeclampsia, did not show any difference between the three groups. Thrombocytopenia was seen in 155 of 230 (67%) babies with culture-proven sepsis. The clinical profile and platelet parameters of babies with sepsis-induced thrombocytopenia are shown in Table 2 . The incidence and duration of thrombocytopenia were significantly higher with Gram-negative and fungal infections as compared with those with Gram-positive infections (P<0.01). Platelet count at the onset of sepsis and platelet nadir were significantly lower with Gram-negative and fungal infections ( Figure 2 ). There was an increase in the MPV from baseline, but the difference between the groups was not significant.
Results

Out
The incidence of persistent bacteremia (73/155 vs 5/75, OR 12.4, CI 4.9-31.5) and multiorgan failure (57/155 vs 15/75, OR 2.3, CI 1.2-4.4) was more in neonates with sepsis-induced thrombocytopenia than in those without thrombocytopenia. Among patients with thrombocytopenia, multiorgan failure was more common with Gram-negative and fungal infections (P<0.03). Echocardiography and an examination of the great vessels in these patients were normal. With a mean duration of 6 days or less, no patient developed mutiorgan failure, whereas all patients developed multiorgan failure when the mean duration of thrombocytopenia was 10 days or more (P<0.001).The effect of different organisms on various parameters is shown in Table 3 . Gram-negative and fungal organisms affected all platelet parameters to a significant degree than did Gram-positive organisms. The mortality in babies with sepsis-induced thrombocytopenia was statistically significant (65/155 vs 18/75, RR ¼ 2. 2, CI 1.2-4.2) and those with Gram-negative and fungal sepsis had the worst outcome (P<0.03, Table 4 ). The poor prognostic factors on multiple logistic regression analysis included a high SNAP score at admission, a severe drop in platelet count at onset of sepsis, a low platelet nadir, a prolonged duration of thrombocytopenia, a need for platelet transfusion, less number of days off ventilation and a prolonged stay in the hospital.
Discussion
Our study shows an organism-specific platelet response in thrombocytopenic VLBW babies with sepsis and the worst outcome for thrombocytopenic neonates with Gram-negative and fungal infections
The incidence of neonatal sepsis is high in developing countries (1.7-33 of 1000 live births) and in Asia, it clusters around 15 of 1000 live births. 15 This higher incidence as also seen in our study is because of ineffective infection control in maternity services, poor sanitation, poor supervision during pregnancy and poor postnatal infection control practices. Moreover, a high percentage of VLBW and extremely low birth weight babies survive and stay for longer periods in nurseries, increasing the incidence of late onset sepsis.
Gram-negative organisms are the commonest cause of neonatal sepsis in both developed and developing countries. 16 A review of 11 471 blood samples from all developing nations of the world revealed that Gram-negative rods were isolated in 60% of positive cultures, 15 with Klebsiella pneumoniae being the commonest organism. The national neonatal perinatal database for the year 2002-2003 from India has also shown Klebsiella pneumoniae as being the major pathogen (27-32%) in both intramural and extramural neonates. 17 Similar trends were observed in our patients. The incidence of neonatal sepsis secondary to Grampositive organisms is less in the Indian subcontinent. Group B streptococcus has been reported uncommonly as a cause of earlyonset sepsis in India. 15, 18 The incidence of late onset sepsis secondary to CoNS is less common in developing countries, as also seen in our study. 15, 19 The lower rates of infection at our centers could be secondary to less-invasive device use.
The incidence of meningitis in our patients was 13%. Similar figures have been reported from Israel. 20 The high incidence in our patients could be because of the predominance of Gram-negative organisms as compared with CoNS in the United States and Europe, which are less virulent, where meningitis is rare and bacteremia can be easily eradicated.
Thrombocytopenia occurs in 20-50% of all neonates admitted to neonatal intensive care units, and the incidence is 50% among preterm babies. [21] [22] [23] [24] The incidence (67%) and duration (8 days for Gram-negative and fungal infections and 2.8 days for Grampositive infections) of thrombocytopenia in VLBW babies with culture-proven sepsis in our study were more as compared with the incidence (54%) and duration (2 days for Gram-negative and fungal infections and 0.4 days for Gram-positive infections) in the study by Guida et al. 7 There are many reasons for this disparity.
The number of patients with Gram-negative and fungal infections was 80% in our study, as against 24% in the study by Guida et al. 7 , and a majority of these babies developed thrombocytopenia (54%). Gram-negative and fungal sepsis-induced thrombocytopenia in preterm babies is very severe and takes more than 7 days for the platelet count to return to baseline. 24 Our babies were more sick as reflected by the high SNAP score at admission. The incidence of persistent bacteremia and multiorgan failure was more in these babies. Although echocardiography did not show endocarditis in any of the patients, the possibility of a small endovascular focus that might not be picked up by echocardiography cannot be ruled out. Moreover, 30% of the organisms, mainly Klebsiella pneumoniae, were extended spectrum b-lactamase producers (unpublished data). All these factors could prolong sepsis and possibly the incidence and duration of thrombocytopenia, inspite of adequate antibiotic coverage.
In patients with early-onset sepsis, Gram-negative organisms were cultured more frequently, as is the trend in most of the developing countries. 15, 18 A similar pattern of Gram-negative organisms in neonates with early-onset sepsis is reported by Stoll et al. 25 Mortality in neonates with early-onset/perinatal sepsis was more (57%) than in neonates with postnatal/nosocomial sepsis (39%).
Gram-negative organisms were the commonest cause of postnatal/nosocomial sepsis in VLBW babies in our study. A similar trend of Gram-negative organisms being the commonest cause of nosocomial sepsis in neonatal intensive care has been reported by other studies. 26 Among the Gram-negative organisms, Klebsiella pneumoniae caused the maximum effect on various platelet parameters. Klebsiella pneumoniae expresses a smooth lipopolysaccharide (LPS with O antigen) and a capsular polysaccharide (K antigen), and both are important for its virulence. There is a variation in the genetic makeup of O antigen between Klebsiella pneumoniae and other Gram-negative organisms, which allows Klebsiella pneumoniae strains to constitutively express a polysaccharide capsule critical for the organism's ability to resist complement-mediated opsonophagocytic killing. [27] [28] These genetic variations in Klebsiella pneumoniae may be responsible for the persistent bacteremia and maximum effects on various platelet parameters, as seen in our study.
The mortality in patients with fungal sepsis was 30%. The mortality was 36% (5/14) in patients with thrombocytopenia as against 16% (1/6) in those without thrombocytopenia. Mortality rates of 37-40% have been reported in literature among very low birth weight babies with fungal sepsis. 29, 30 Prophylactic fluconazole has proven to be very effective in decreasing the incidence of fungal colonization and systemic fungal infection in neonates, 31 and might be helpful in decreasing mortality if started early, especially in VLBW babies.
Platelets not only mediate hemostasis but also have an important role in linking innate and adaptive immune systems through the expression of Toll-like receptors. [32] [33] Lipopolysaccharide binds to platelets through Toll-like receptor 4, which is present on their surface, and, together with autoantibodies (present in 54% of patients with sepsis), significantly enhances Fc-mediated platelet phagocytosis by mononuclear phagocytes. 34, 35 Platelet Toll-like receptor 4 expression also mediates lipopolysaccharide-mediated thrombocytopenia and the release of tumor necrosis factor-a by causing platelet sequestration in the lungs in the presence of neutrophils. 36 As endotoxemia is often accompanied by a microvascular inflammatory response, 37, 38 cytokines and bacterial lipopolysaccharide probably trigger this response through the activation of platelets, leukocytes or both. This microvascular inflammatory response could be responsible for the multiorgan failure that occurs with sepsis in preterm babies.
Conclusion
Our study shows an organism-specific platelet response and an increased incidence of persistent bacteremia, multiorgan failure and death in thrombocytopenic VLBW neonates with sepsis. The poor prognostic factors include a high SNAP score at admission, a prolonged duration of thrombocytopenia, a very low platelet nadir, persistent bacteremia, multiorgan failure, a need for platelet transfusion and a prolonged stay in the hospital. Further studies are needed to better correlate the relationship between prolonged thrombocytopenia and outcome in very low birth weight babies with sepsis.
